Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jill Langer

Diagnostic Radiology Philadelphia, PA Medical Doctor

NPI 1003844192 CMS profile 505764

3400 Spruce Street, Ground Floor Dulles, Philadelphia, PA 19104

Open in the dashboard

General payments

$895,416

583 records reported · program years 2019–2025

Research payments

$1,200,638

Paid to them · 92 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jill Langer of Philadelphia, PA is reported in the CMS Open Payments database as having received $895,416 across 583 general payments and $1,200,638 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $83,310 23
2025 Research $61,250 22
2024 General $46,515 12
2024 Research $82,568 10
2023 General $80,590 14
2023 Research $155,725 10
2022 General $3,650 5
2022 Research $169,958 12
2021 General $263,580 185
2021 Research $212,303 14
2020 General $261,858 202
2020 Research $235,335 12
2019 General $155,913 142
2019 Research $283,500 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jill Langer
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Jill Langer were reported at $83,310. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Jill Langer Diagnostic Radiology median Middle half National median
2019 $155,913 $108 $29–$318 $163
2020 $261,858 $65 $21–$252 $114
2021 $263,580 $92 $24–$292 $132
2022 $3,650 $104 $29–$294 $149
2023 $80,590 $110 $29–$337 $160
2024 $46,515 $113 $30–$356 $164
2025 $83,310 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $681,351 529 payments
  2. Pfizer Inc. $84,990 24 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $70,555 17 payments
  4. Seattle Genetics, Inc. $44,835 11 payments
  5. Boehringer Ingelheim International GmbH $13,685 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $895,416 583 payments
Products named General payments · program years 2019–2025
  1. KEYTRUDA $561,186 472 payments
  2. LENVIMA $69,405 27 payments
  3. WELIREG $26,535 12 payments
  4. MK-6482 $2,430 5 payments
  5. MK-7339 $150 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $1,148,923 79 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $34,885 8 payments
  3. Regeneron Pharmaceuticals, Inc. $9,120 3 payments
  4. Boehringer Ingelheim International GmbH $3,960 1 payment
  5. Genentech, Inc. $3,750 1 payment

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$41,474

Medicare's payments for the services billed

Medicare patients

954

Average age 71

Services billed

1,383

483 women, 471 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 45%
Chronic kidney disease 41%
Diabetes 38%
Ischemic heart disease 37%
Heart failure 29%
Cancer 29%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

675 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record